Description
Panobinostat, marketed under the brand name FARYDAK, It is an prescription medication that has been approved panobinostat (Farydak) on February 23, 2015 for the treatment of multiple myeloma. The FDA approved panobinostat under its accelerated approval program, which provides earlier access to promising new drugs.
What is FARYDAK (panobinostat) ?
FARYDAK, a histone deacetylase inhibitor, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent. This indication is approved under accelerated approval based on progression free survival. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
Source Content From US FDA
How to order approved “FARYDAK (panobinostat) for capsules” Medicine?
FARYDAK (Panobinostat) Capsules is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing FARYDAK and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
